E-ZYVEC Trademark

Trademark Overview


On Friday, May 13, 2022, a trademark application was filed for E-ZYVEC with the United States Patent and Trademark Office. The USPTO has given the E-ZYVEC trademark a serial number of 79346549. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 4, 2025. This trademark is owned by POLYPLUS TRANSFECTION. The E-ZYVEC trademark is filed in the Chemical Products and Computer & Software Services & Scientific Services categories with the following description:

Chemical and biochemical preparations for scientific use and for research, other than for medical or veterinary use; chemical and biochemical preparations for scientific use and for research in the field of genetics, for transferring biological molecules into living cells, integrating foreign nucleic acids into living cell genomes and producing transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and pseudo-viral particles; chemical preparations, agents and reagents for scientific use and for scientific research for genetic diagnosis other than for medical or veterinary use; chemical and biochemical test kits and tests for improving transient genetic expression of genes in cells for scientific use and for scientific research comprising preparations, agents and reagents; chemical and biochemical test kits and tests for scientific use and for scientific research comprising preparations, agents and reagents in the field of genetics, for transferring biologica...

Chemical and biochemical analyses; genetic analyses for genetic research; structural and functional analysis of genomes; analyses in the field of molecular biology; scientific analyses and research in the field of transfection; designing software and computer software in the field of scientific research and genetic analyses; consulting in relation to research and development of transfections agents and agents, reagents and chemicals and biochemicals used in the field of genetics; development of pharmaceutical products; developing transfection agents for scientific research; scientific development of new products in the field of gene therapies; computer-aided scientific testing of DNA samples for diagnostic purposes; scientific research laboratory services in the field of genetics and genetic engineering; conducting clinical trials for third parties for pharmaceutical and genetic products; scientific research with respect to medicines; scientific research in the field of genetics and ge...
e-zyvec

General Information


Serial Number79346549
Word MarkE-ZYVEC
Filing DateFriday, May 13, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 4, 2025

Trademark Statements


Goods and ServicesChemical and biochemical preparations for scientific use and for research, other than for medical or veterinary use; chemical and biochemical preparations for scientific use and for research in the field of genetics, for transferring biological molecules into living cells, integrating foreign nucleic acids into living cell genomes and producing transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and pseudo-viral particles; chemical preparations, agents and reagents for scientific use and for scientific research for genetic diagnosis other than for medical or veterinary use; chemical and biochemical test kits and tests for improving transient genetic expression of genes in cells for scientific use and for scientific research comprising preparations, agents and reagents; chemical and biochemical test kits and tests for scientific use and for scientific research comprising preparations, agents and reagents in the field of genetics, for transferring biological molecules into living cells, integrating foreign nucleic acids into living cell genomes and producing transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and/or pseudo-viral particles
Goods and ServicesChemical and biochemical analyses; genetic analyses for genetic research; structural and functional analysis of genomes; analyses in the field of molecular biology; scientific analyses and research in the field of transfection; designing software and computer software in the field of scientific research and genetic analyses; consulting in relation to research and development of transfections agents and agents, reagents and chemicals and biochemicals used in the field of genetics; development of pharmaceutical products; developing transfection agents for scientific research; scientific development of new products in the field of gene therapies; computer-aided scientific testing of DNA samples for diagnostic purposes; scientific research laboratory services in the field of genetics and genetic engineering; conducting clinical trials for third parties for pharmaceutical and genetic products; scientific research with respect to medicines; scientific research in the field of genetics and genetic engineering; scientific research for medical purposes; providing temporary use of non-downloadable computer software to assist in the custom design of DNA vectors for scientific research

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, August 5, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 5, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePOLYPLUS TRANSFECTION
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressFR

Party NamePOLYPLUS TRANSFECTION
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressFR

Trademark Events


Event DateEvent Description
Thursday, August 4, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 5, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 9, 2022APPLICATION FILING RECEIPT MAILED
Friday, March 3, 2023ASSIGNED TO EXAMINER
Monday, March 13, 2023NON-FINAL ACTION WRITTEN
Tuesday, March 14, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, May 2, 2023REFUSAL PROCESSED BY MPU
Wednesday, May 3, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, May 24, 2023REFUSAL PROCESSED BY IB
Tuesday, October 31, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 31, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 31, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 10, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, January 10, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, January 29, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, March 5, 2024FINAL REFUSAL WRITTEN
Tuesday, March 5, 2024FINAL REFUSAL E-MAILED
Tuesday, March 5, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, September 5, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 5, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, November 6, 2024ASSIGNED TO EXAMINER
Sunday, January 12, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 29, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 4, 2025PUBLISHED FOR OPPOSITION
Tuesday, February 4, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, September 5, 2024TEAS/EMAIL CORRESPONDENCE ENTERED